Development of technology and mobile diagnostic apparatus based on a lab-on-track solution to detect infectious diseases (Q78118): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fixing rounding issue)
(‎Removed claim: summary (P836): The project concerns the R & D work and the pre-implementation work to lead to the development and commercialisation of an innovative international (molecular diagnostic) diagnostic apparatus for detection of dangerous infectious diseases in the period 2019-2022:1/Chlamydia tracheitis 2/Chlamydophila pneumoniae 3/Mycoplasma OF pneumoniae 4/Neisseria meningitidis 5/Neisseria A solution is to be based on the author (SNAAT) and the use of an insu...)
Property / summary
The project concerns the R & D work and the pre-implementation work to lead to the development and commercialisation of an innovative international (molecular diagnostic) diagnostic apparatus for detection of dangerous infectious diseases in the period 2019-2022:1/Chlamydia tracheitis 2/Chlamydophila pneumoniae 3/Mycoplasma OF pneumoniae 4/Neisseria meningitidis 5/Neisseria A solution is to be based on the author (SNAAT) and the use of an insulating technique used by the GENOMTEC technique (LOC) and the use of an insulating technique.The examination process shall be carried out by means of a non-maintenance copy of the reaction card and of the control device.THE DIAGNOSTIC APPARATUS WILL BE THE FIRST FOR THE WORLD MARKET, A MOBILE SOLUTION FOR RAPID AND ACCURATE MOLECULAR TESTING AT ANY PLACE, BY MEDICAL PERSONNEL, WITHOUT LABORATORY EXPERIENCE (WHILE MAINTAINING PRICE COMPETITIVENESS OF THE PRODUCT).THIS WILL ALLOW FOR THE EARLY DETECTION OF DISEASES AND THE USE OF APPROPRIATE TREATMENTS.Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26 (English)
 
Property / summary: The project concerns the R & D work and the pre-implementation work to lead to the development and commercialisation of an innovative international (molecular diagnostic) diagnostic apparatus for detection of dangerous infectious diseases in the period 2019-2022:1/Chlamydia tracheitis 2/Chlamydophila pneumoniae 3/Mycoplasma OF pneumoniae 4/Neisseria meningitidis 5/Neisseria A solution is to be based on the author (SNAAT) and the use of an insulating technique used by the GENOMTEC technique (LOC) and the use of an insulating technique.The examination process shall be carried out by means of a non-maintenance copy of the reaction card and of the control device.THE DIAGNOSTIC APPARATUS WILL BE THE FIRST FOR THE WORLD MARKET, A MOBILE SOLUTION FOR RAPID AND ACCURATE MOLECULAR TESTING AT ANY PLACE, BY MEDICAL PERSONNEL, WITHOUT LABORATORY EXPERIENCE (WHILE MAINTAINING PRICE COMPETITIVENESS OF THE PRODUCT).THIS WILL ALLOW FOR THE EARLY DETECTION OF DISEASES AND THE USE OF APPROPRIATE TREATMENTS.Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26 (English) / rank
Normal rank
 

Revision as of 11:14, 14 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Development of technology and mobile diagnostic apparatus based on a lab-on-track solution to detect infectious diseases
Project in Poland financed by DG Regio

    Statements

    country
    Poland
    0 references
    EU contribution
    8,912,385.14 zloty
    0 references
    2,138,972.43 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    budget
    12,210,584.19 zloty
    0 references
    2,930,540.21 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    co-financing rate
    72.99 percent
    0 references
    start time
    1 January 2019
    0 references
    end time
    30 November 2022
    0 references
    beneficiary name (string)
    GENOMTEC SPÓŁKA AKCYJNA
    0 references
    beneficiary
    Q2510195
    0 references
    coordinate location

    51°7'34.7"N, 16°58'41.5"E
    0 references
    summary
    Projekt dotyczy prac B+R oraz prac przedwdrożeniowych, które mają doprowadzić do opracowania i komercjalizacji w latach 2019-2022 innowacyjnej w skali międzynarodowej aparatury diagnostycznej (z obszaru diagnostyki molekularnej) przeznaczonej do detekcji patogenów groźnych chorób zakaźnych: 1/ Chlamydia trachomatis 2/ Chlamydophila pneumoniae 3/ Mycoplasma pneumoniae 4/ Neisseria meningitidis 5/ Neisseria gonorrhoeae 6/ MRSA Rozwiązanie ma opierać się na autorskiej technologii GENOMTEC pod nazwą SNAAT (Simplified Nucleic Acid Amplification Technology) z uwzględnieniem rozwiązań typu Laboratory-on-Chip (LOC) I wykorzystaniu techniki izotermalnej LAMP. Proces diagnostyczny przebiegać będzie przy użyciu bezobsługowej karty reakcyjnej oraz urządzenia sterującego. APARATURA DIAGNOSTYCZNA BĘDZIE PIERWSZYM NA RYNKU ŚWIATOWYM, MOBILNYM ROZWIĄZANIEM UMOŻLIWIAJĄCYM SZYBKIE I PRECYZYJNE WYKONYWANIE BADAŃ MOLEKULARNYCH W KAŻDYM MIEJSCU, PRZEZ PERSONEL MEDYCZNY, BEZ KONIECZNOŚCI DOŚWIADCZENIA LABORATORYJNEGO (PRZY ZACHOWANIU KONKURENCYJNOŚCI CENOWEJ PRODUTKU). DZIĘKI TEMU MOŻLIWE BĘDZIE WCZESNE WYKRYCIE CHORÓB I ZASTOSOWANIE ODPOWIEDNIEJ TERAPII. Numer_referencyjny_programu_pomocowego: SA.41471(2015/X) Przeznaczenie_pomocy_publicznej: art. 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26 (Polish)
    0 references

    Identifiers

    Polish Kohesio ID
    POIR.01.01.01-00-0563/18
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q78118&oldid=6331456"